Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Clinical profiling and outcomes of ischemic stroke patients with immune thrombocytopenia: A multicenter real-world study

Liqin Cao, Jin Wu, Fan Zhou, Dengju Li, LiLi Ji, ZhuRuoHan Yu, Yuping Gong, Kaiteng Cai, Guoyang Zhuang, YanYan Xie, Xiaolu Zhu, Qiu-Sha Huang, Hai-Xia Fu, ZePing Zhou, Xiaojun Huang, Xiaohui Zhang

Blood (2025) 146 (Supplement 1): 1264.

https://doi.org/10.1182/blood-2025-1264

Published: 2025

Journal Articles

Probiotics supplementation ameliorates bone marrow mesenchymal stem cells injury via IFN-I/STAT1 signaling pathway in immune thrombocytopenia during pregnancy

Qi Chen, Jian-Ying Zhou, Meng-Yu Xiao, Qiu-Sha Huang, Hai-Xia Fu, Xiaohui Zhang

Blood (2025) 146 (Supplement 1): 1246.

https://doi.org/10.1182/blood-2025-1246

Published: 2025

Journal Articles

Iguratimod plus low-dose rituximab as second-line treatment in adults with primary immune thrombocytopenia: A multicenter, open-label, randomized, controlled, Phase 2 trial

Qiu-Sha Huang, Zhuo-Yu An, Peng Zhao, Qi Chen, Jin Wu, Hai-Xia Fu, Yujun Dong, Hongmei Jing, Liping Dou, Hui Liu, Yi Liu, Lanping Xu, Xiaojun Huang, Xiaohui Zhang

Blood (2025) 146 (Supplement 1): 3044.

https://doi.org/10.1182/blood-2025-3044

Published: 2025

Journal Articles

The selective JAK1 inhibitor upadacitinib restores impaired neutrophil chemotaxis in the proplatelet formation of immune thrombocytopenia

Qiu-Sha Huang, Qing-Yuan Qu, Zhuo-Yu An, Peng Zhao, Qi Chen, Jin Wu, Hai-Xia Fu, Ying-Jun Chang, Xiang-Yu Zhao, Lanping Xu, Xiaojun Huang, Xiaohui Zhang

Blood (2025) 146 (Supplement 1): 197.

https://doi.org/10.1182/blood-2025-197

Published: 2025

Journal Articles

Single-cell dissection of pathogenic T-cell response to tacrolimus in immune thrombocytopenia

Li-Ping Yang, Peng Zhao, Qiu-Sha Huang, Xiang-Yu Zhao, Qian Jiang, Ying-Jun Chang, Lanping Xu, Xiaojun Huang, Xiaohui Zhang

Blood (2025) 146 (Supplement 1): 3024.

https://doi.org/10.1182/blood-2025-3024

Published: 2025

Journal Articles

Management and outcomes of acute coronary syndromes in patients with immune thrombocytopenia: A single-center real-world study

Jin Wu, Liqin Cao, Qiu-Sha Huang, Zhuo-Yu An, Peng Zhao, Hai-Xia Fu, Xiaohui Zhang

Blood (2025) 146 (Supplement 1): 4822.

https://doi.org/10.1182/blood-2025-4822

Published: 2025

Journal Articles

The JAK1/2 inhibitor baricitinib revealed unique immune biomarkers in multirefractory immune thrombocytopenia patients

Zhuo-Yu An, Peng Zhao, Hai-Xia Fu, Xiaolu Zhu, Yun He, Qiu-Sha Huang, Xiaohui Zhang

Blood (2025) 146 (Supplement 1): 4820.

https://doi.org/10.1182/blood-2025-4820

Published: 2025

Journal Articles

Baricitinib reveals LGALS3BP as a novel pathogenic factor and therapeutic target in immune thrombocytopenia

Kexin Shen, Jingli Han, Zhuo-Yu An, Peng Zhao, Hai-Xia Fu, Qiu-Sha Huang, Jin Wu, Li-Ping Yang, Yuanyuan Zhang, Ying-jun Chang, Xiangyu Zhao, Yu Wang, Lan-Ping Xu, Xiaojun Huang, Xiaohui Zhang

Blood (2025) 146 (Supplement 1): 846.

https://doi.org/10.1182/blood-2025-846

Published: 2025

Journal Articles

Outcome and recovery trajectories for intracerebral hemorrhage in adults with primary immune thrombocytopenia

Peng Zhao, Ming Hou, Yi Liu, Ru Feng, Yujun Dong, Hai-Xia Fu, Qiu-Sha Huang, Jin Wu, Zhuoyu An, Yuanyuan Zhang, Xiangyu Zhao, Ying-jun Chang, Lan-Ping Xu, Xiaojun Huang, Xiaohui Zhang

Blood (2025) 146 (Supplement 1): 3033.

https://doi.org/10.1182/blood-2025-3033

Published: 2025

Journal Articles

Development and prospective validation of a prognostic model for diffuse alveolar hemorrhage after allogeneic hematopoietic stem cell transplantation

Qiu-Sha Huang, Zhuo-Yu An, Peng Zhao, Xiaolu Zhu, Yun He, Hai-Xia Fu, Fengrong Wang, Yuanyuan Zhang, Xiao-Dong Mo, Wei Han, Chen-hua Yan, Ting-ting Han, Yao Chen, Yu Wang, Ying-Jun Chang, Xiang-Yu Zhao, Lanping Xu, Xiaojun Huang, Xiaohui Zhang

Blood (2025) 146 (Supplement 1): 4276.

https://doi.org/10.1182/blood-2025-4276

Published: 2025

Journal Articles

Acute myocardial infarction following allogeneic hematopoietic stem cell transplantation: Lessons learned from a national representative study

Peng Zhao, Zhixue Li, Erlie Jiang, Shengjin Fan, Pengcheng He, Jingzhi Wang, Linghui Xia, Qiu-Sha Huang, Jin Wu, Zhuoyu An, Hai-Xia Fu, Yuanyuan Zhang, Xiangyu Zhao, Yu Wang, Lan-Ping Xu, Xiaojun Huang, Xiaohui Zhang

Blood (2025) 146 (Supplement 1): 4263.

https://doi.org/10.1182/blood-2025-4263

Published: 2025

Journal Articles

Projected Global Trends in Hematological Malignancies: Incidence, Mortality, and Disability-Adjusted Life Years from 2020 to 2030

Zhuo-Yu An, Haixia Fu, Yun He, Xiaolu Zhu, Qiu-Sha Huang, Jin Wu, Kaiyan Liu, Xiaohui Zhang

Blood (2023) 142 (Supplement 1): 3810.

https://doi.org/10.1182/blood-2023-187856

Published: 2023

Journal Articles

Baricitinib in Combination with High-Dose Dexamethasone As First-Line Treatment for Newly Diagnosed Immune Thrombocytopenia: A Prospective, Multicenter, Randomized Trial

Blood (2023) 142 (Supplement 1): 1207.

https://doi.org/10.1182/blood-2023-181622

Published: 2023

Journal Articles

Tacrolimus and Danazol Combination As a Second-Line Therapeutic Strategy for Steroid-Resistant or Relapsed Immune Thrombocytopenia: A Prospective, Randomized, Multicenter, Open-Label Study

Zhuo-Yu An, Yun He, Xiao-lu Zhu, Qiu-Sha Huang, Jin Wu, Haixia Fu, Yuan-Yuan Zhang, Ying-jun Chang, Xiangyu Zhao, Kaiyan Liu, Xiaohui Zhang

Blood (2023) 142 (Supplement 1): 2582.

https://doi.org/10.1182/blood-2023-188139

Published: 2023

Journal Articles

Evaluation of ISTH Severe Bleeding Criteria and Development of a Mortality Prognosis Model for Hospitalized Immune Thrombocytopenia Patients: A Multicenter, Retrospective and Prospective Cohort Study

Zhuo-Yu An, Haixia Fu, Yun He, Xiaolu Zhu, Jin Wu, Qiu-Sha Huang, Kaiyan Liu, Xiaohui Zhang

Blood (2023) 142 (Supplement 1): 2580.

https://doi.org/10.1182/blood-2023-187920

Published: 2023

Journal Articles

High Dimensional Single-Cell Profiling Identifies Immune and Metabolic Heterogeneity in Immune Thrombocytopenia

Li-Ping Yang, Hai-Xia Fu, Peng Zhao, Jin Wu, Qiu-Sha Huang, Yuan-Yuan Zhang, Jun Kong, Zhi-Dong Wang, Jing Liu, Kaiyan Liu, Xiao Jun Huang, Xiaohui Zhang

Blood (2023) 142 (Supplement 1): 2585.

https://doi.org/10.1182/blood-2023-185457

Published: 2023

Journal Articles

All- trans retinoic acid plus low-dose rituximab vs low-dose rituximab in corticosteroid-resistant or relapsed ITP

Ye-Jun Wu, Hui Liu, Qiao-Zhu Zeng, Yi Liu, Jing-Wen Wang, Wen-Sheng Wang, Jia-Feng, He-Bing Zhou, Qiu-Sha Huang, Yun He, Hai-Xia Fu, Xiao-Lu Zhu, Qian Jiang, Hao Jiang, Ying-Jun Chang, Lan-Ping Xu, Xiao-Jun Huang, Xiao-Hui Zhang

Blood (2022) 139 (3): 333–342.

https://doi.org/10.1182/blood.2021013393

Published: 2022

Includes: Supplemental data

Journal Articles

Tacrolimus Plus High-Dose Dexamethasone Versus High-Dose Dexamethasone Alone As First-Line Treatment for Adult Immune Thrombocytopenia: The Phase 2, Open Label, Randomized Trial (TARGET 020)

Blood (2021) 138 (Supplement 1): 13.

https://doi.org/10.1182/blood-2021-152111

Published: 2021

Journal Articles

All-Trans Retinoic Acid Plus Low-Dose Rituximab Vs Low-Dose Rituximab in Corticosteroid-Resistant or Relapsed ITP

Ye-Jun Wu, Hui Liu, Qiao-Zhu Zeng, Yi Liu, Jing-Wen Wang, Wen-Sheng Wang, Jia Feng, He-Bing Zhou, Qiu-Sha Huang, Hai-Xia Fu, Xiao-Lu Zhu, Yun He, Hao Jiang, Ying-Jun Chang, Lan-Ping Xu, Xiao-Jun Huang, Xiao-Hui Zhang

Blood (2021) 138 (Supplement 1): 15.

https://doi.org/10.1182/blood-2021-149527

Published: 2021

Journal Articles

Machine-Learning Model for Resistance/Relapse Prediction in Immune Thrombocytopenia Using Gut Microbiota and Function Signatures

Feng-Qi Liu, Qi Chen, Qingyuan Qu, Xueyan Sun, Qiu-Sha Huang, Yun He, Xiaolu Zhu, Chencong Wang, Hai-Xia Fu, Yue-Ying Li, Qian-fei Wang, Kai-Yan Liu, Xiao-Hui Zhang

Blood (2021) 138 (Supplement 1): 18.

https://doi.org/10.1182/blood-2021-148987

Published: 2021

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Clinical profiling and outcomes of ischemic stroke patients with immune thrombocytopenia: A multicenter real-world study

Probiotics supplementation ameliorates bone marrow mesenchymal stem cells injury via IFN-I/STAT1 signaling pathway in immune thrombocytopenia during pregnancy

Iguratimod plus low-dose rituximab as second-line treatment in adults with primary immune thrombocytopenia: A multicenter, open-label, randomized, controlled, Phase 2 trial

The selective JAK1 inhibitor upadacitinib restores impaired neutrophil chemotaxis in the proplatelet formation of immune thrombocytopenia

Single-cell dissection of pathogenic T-cell response to tacrolimus in immune thrombocytopenia

Management and outcomes of acute coronary syndromes in patients with immune thrombocytopenia: A single-center real-world study

The JAK1/2 inhibitor baricitinib revealed unique immune biomarkers in multirefractory immune thrombocytopenia patients

Baricitinib reveals LGALS3BP as a novel pathogenic factor and therapeutic target in immune thrombocytopenia

Outcome and recovery trajectories for intracerebral hemorrhage in adults with primary immune thrombocytopenia

Development and prospective validation of a prognostic model for diffuse alveolar hemorrhage after allogeneic hematopoietic stem cell transplantation

Acute myocardial infarction following allogeneic hematopoietic stem cell transplantation: Lessons learned from a national representative study

Projected Global Trends in Hematological Malignancies: Incidence, Mortality, and Disability-Adjusted Life Years from 2020 to 2030

Baricitinib in Combination with High-Dose Dexamethasone As First-Line Treatment for Newly Diagnosed Immune Thrombocytopenia: A Prospective, Multicenter, Randomized Trial

Tacrolimus and Danazol Combination As a Second-Line Therapeutic Strategy for Steroid-Resistant or Relapsed Immune Thrombocytopenia: A Prospective, Randomized, Multicenter, Open-Label Study

Evaluation of ISTH Severe Bleeding Criteria and Development of a Mortality Prognosis Model for Hospitalized Immune Thrombocytopenia Patients: A Multicenter, Retrospective and Prospective Cohort Study

High Dimensional Single-Cell Profiling Identifies Immune and Metabolic Heterogeneity in Immune Thrombocytopenia

All- trans retinoic acid plus low-dose rituximab vs low-dose rituximab in corticosteroid-resistant or relapsed ITP

Tacrolimus Plus High-Dose Dexamethasone Versus High-Dose Dexamethasone Alone As First-Line Treatment for Adult Immune Thrombocytopenia: The Phase 2, Open Label, Randomized Trial (TARGET 020)

All-Trans Retinoic Acid Plus Low-Dose Rituximab Vs Low-Dose Rituximab in Corticosteroid-Resistant or Relapsed ITP

Machine-Learning Model for Resistance/Relapse Prediction in Immune Thrombocytopenia Using Gut Microbiota and Function Signatures

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only